ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
On November 26, 2025, the United States Patent and Trademark Office (USPTO) issued revised guidelines for determining inventorship of ...
The United States Patent and Trademark Office (USPTO) has issued an advance notice of change to the Manual of Patent Examining Procedure (MPEP) ...
Price hikes at ‘big law’ firms are pushing some clients toward boutiques that offer predictable fees, specialised expertise, ...
The Harbor Health Care ETF MEDI is now three years old and has performed so well that it has been rated five stars (the highest rating) within Morningstar's U.S. Fund Health category. The ...
Discover why AbbVie (ABBV) is rated Strong Buy, with robust 2025 growth, diversified revenues, and attractive valuation.
Electronic gifts are very popular, and in recent years, retailers have been offering significant discounts on smartphones, ...
Artificial intelligence patenting in insurance is becoming a high-stakes, highly concentrated race dominated by a handful of U.S. carriers.
Mindpeak, a global pioneer in AI-powered pathology solutions, is today thrilled to announce that it has been granted its first patent, covering a groundbreaking novel way to train an AI system so it ...
Pravin Anand and Ashutosh Upadhyaya of Anand and Anand examine whether taste can function as a trademark in India, with ...
The patent grants Inspira exclusive commercial rights in the patented Dual Lumen Cannula technology in Japan through 2041. This milestone complements the Company’s existing U.S. Patent (granted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback